Evidence-Based Decision Making 3 : Health Technology Assessment
This chapter begins with a brief introduction to health technology assessment (HTA). HTA is concerned with the systematic evaluation of the consequences of the adoption and use of new health technologies and to improve the evidence on existing technologies. The objective of mainstream HTA is to support evidence-based decision- and policy-making that encourage the uptake of efficient and effective health-care technologies. This chapter provides a basic framework for conducting an HTA, as well as some fundamental concepts and challenges in assessing health technologies. Whether HTA is beneficial-supporting timely access to needed technologies-or detrimental depends on three critical issues: when the assessment is performed; how it is performed; and how the findings are used.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2249 |
|---|---|
| Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 2249(2021) vom: 19., Seite 429-454 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Reilly, Daria [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Economic evaluation |
|---|
| Anmerkungen: |
Date Completed 22.06.2021 Date Revised 22.06.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/978-1-0716-1138-8_23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324264747 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324264747 | ||
| 003 | DE-627 | ||
| 005 | 20231225185938.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-1-0716-1138-8_23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1080.xml |
| 035 | |a (DE-627)NLM324264747 | ||
| 035 | |a (NLM)33871857 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Reilly, Daria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evidence-Based Decision Making 3 |b Health Technology Assessment |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.06.2021 | ||
| 500 | |a Date Revised 22.06.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a This chapter begins with a brief introduction to health technology assessment (HTA). HTA is concerned with the systematic evaluation of the consequences of the adoption and use of new health technologies and to improve the evidence on existing technologies. The objective of mainstream HTA is to support evidence-based decision- and policy-making that encourage the uptake of efficient and effective health-care technologies. This chapter provides a basic framework for conducting an HTA, as well as some fundamental concepts and challenges in assessing health technologies. Whether HTA is beneficial-supporting timely access to needed technologies-or detrimental depends on three critical issues: when the assessment is performed; how it is performed; and how the findings are used | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Economic evaluation | |
| 650 | 4 | |a Evidence-based decision-making | |
| 650 | 4 | |a Health policy | |
| 650 | 4 | |a Health technology assessment | |
| 650 | 4 | |a Health-care technology | |
| 700 | 1 | |a Audas, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Kaitryn |e verfasserin |4 aut | |
| 700 | 1 | |a Vanstone, Meredith |e verfasserin |4 aut | |
| 700 | 1 | |a Bowen, James M |e verfasserin |4 aut | |
| 700 | 1 | |a Schwartz, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Assasi, Nazila |e verfasserin |4 aut | |
| 700 | 1 | |a Goeree, Ron |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 2249(2021) vom: 19., Seite 429-454 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
| 773 | 1 | 8 | |g volume:2249 |g year:2021 |g day:19 |g pages:429-454 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-0716-1138-8_23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2249 |j 2021 |b 19 |h 429-454 | ||